Plasmodium falciparum surface protein Pfs230 (Pfs230)

Plasmodium falciparum surface protein Pfs230 is a large (~3135 amino acids, >300 kDa) sexual stage surface protein belonging to the 6-cysteine protein family, characterized by 14 tandem 6-cysteine domains[1][6][7]. Pfs230 is expressed on the surface of gametocytes (precursors to gametes) and is essential for male gamete fertility and parasite transmission to the mosquito vector[7][2]. During the sexual stage of the parasite lifecycle, Pfs230 mediates red blood cell binding, exflagellation center formation, and oocyst development in the mosquito gut[2][7]. Disruption of Pfs230 results in dramatic reduction in oocyst production and impaired parasite transmission[2]. Pfs230 is one of the most advanced antigens under clinical development as a component of malaria transmission-blocking vaccines (TBVs), whose mechanism depends on eliciting antibodies that prevent parasite fertilization or oocyst development in mosquitoes[1][8][5]. Several functional domains, particularly the N-terminal (Pro-D1) and domain 7, are known to be targets of potent transmission-blocking antibodies[8][5]. Allelic polymorphisms exist but are generally limited in the most clinically relevant N-terminal domains[9]. Vaccine development and structural biology efforts continue to focus on mapping the epitopes and optimizing immunogenicity of Pfs230-based candidates[5][3][9].

Other names

Pfs230 gamete surface antigenMalaria transmission-blocking antigen Pfs230PF3D7_0209000 (gene name)Sexual stage antigen Pfs230

Vaccine-elicited antibodies bind to Pfs230, blocking parasite fertilization and oocyst formation within the mosquito vector, thus interrupting transmission from humans to mosquitoes and vice versa[1][8][5]. Monoclonal antibodies such as mAb 18F25.2a can induce complement-dependent lysis of gametes, blocking transmission[8].